Efficacy of intravenous and subcutaneous guselkumab induction by weight and body mass index in patients with Crohn’s disease: Results from the phase 3 GALAXI and GRAVITI studies

E Schnoy, P Deepak, A J Yarur, T Hisamatsu, R Van Rampelbergh, W van Duijnhoven, S Adsul, D Piscitelli, D T Rubin, S Danese · Zeitschrift für Gastroenterologie · 2026 · Heft 08 · S. e311-e312